z-logo
open-access-imgOpen Access
Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion–Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?
Author(s) -
Steven G. Waguespack,
Sanjit O. Tewari,
Naifa L. Busaidy,
Mark Zafereo
Publication year - 2022
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
ISSN - 2473-4284
DOI - 10.1200/po.21.00467
Subject(s) - thyroid carcinoma , radioactive iodine , medicine , trk receptor , oncology , disease , radioiodine therapy , cancer research , thyroid , receptor , neurotrophin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom